These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7937541)

  • 1. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Uchida T; Martin S; Foster TP; Wardley RC; Grimm S
    Pharm Res; 1994 Jul; 11(7):1009-15. PubMed ID: 7937541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
    Tabata Y; Inoue Y; Ikada Y
    Vaccine; 1996 Dec; 14(17-18):1677-85. PubMed ID: 9032899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT; Jeffery H; Davis SS
    Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release microparticles for vaccine development.
    O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS
    Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
    Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable microparticles as controlled release antigen delivery systems.
    O'Hagan DT; Rahman D; McGee JP; Jeffery H; Davies MC; Williams P; Davis SS; Challacombe SJ
    Immunology; 1991 Jun; 73(2):239-42. PubMed ID: 2071168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation of sustained release erythropoietin microparticle.
    Yeh MK; Chen JL; Chiang CH; Chang ZY
    J Microencapsul; 2007 Feb; 24(1):82-93. PubMed ID: 17438944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitizing mice to ovalbumin through subcutaneous microsphere immunotherapy (SMITH).
    Reisacher WR; Liotta D; Yazdi S; Putnam D
    Int Forum Allergy Rhinol; 2011; 1(5):390-5. PubMed ID: 22287471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
    Uchida T; Yoshida K; Ninomiya A; Goto S
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable microparticles for oral immunization.
    O'Hagan DT; McGee JP; Holmgren J; Mowat AM; Donachie AM; Mills KH; Gaisford W; Rahman D; Challacombe SJ
    Vaccine; 1993; 11(2):149-54. PubMed ID: 8438613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens.
    Saini V; Verma SK; Murthy PK; Kohli D
    Vaccine; 2013 Aug; 31(38):4183-91. PubMed ID: 23827312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice.
    Uchida M; Natsume H; Kishino T; Seki T; Ogihara M; Juni K; Kimura M; Morimoto Y
    Vaccine; 2006 Mar; 24(12):2120-30. PubMed ID: 16356602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release of calcium hydroxide from poly(DL-lactide-co-glycolide) acid microspheres for apexification.
    Cerda-Cristerna BI; Breceda-Leija A; Méndez-González V; Chavarría-Bolaños D; Flores-Reyes H; Garrocho-Rangel A; Komabayashi T; Wadajkar AS; Pozos-Guillén AJ
    Odontology; 2016 Sep; 104(3):318-23. PubMed ID: 26175086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.